Clinical trial
A Prospective, Multicenter, No-treatment Controlled, Randomized, Open-label, Pivotal Study to Evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications
NCT04307836 is registered in ClinicalTrials.gov with Kalos Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, No-treatment Controlled, Randomized, Open-label, Pivotal Study to Evaluate the Safety and Efficacy of DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications
- Lead sponsor
- Kalos Medical
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 9, 2020
- Completion date
- April 17, 2024
- Enrollment
- 140 (estimated)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.